Diabetes, Vol 46, Issue 8 1257-1263, Copyright © 1997 by American Diabetes Association

ARTICLES

CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats

CJ de Souza, MF Hirshman and ES Horton
Joslin Diabetes Center, Boston, Massachusetts, USA. christopher.desouza@pharma.novartis.com

Administration of the murine-selective beta3 adrenoceptor agonist CL-316,243 corrects obesity and elevated blood glucose in diabetic rodents. This antiobesity effect is attributed to an increase in the thermogenic activity of brown adipose tissue (BAT). The antidiabetic effect is unknown, but has been attributed to the decline in body weight and plasma free fatty acids (FFAs). This study using the euglycemic-hyperinsulinemic clamp method was performed in nonobese, nondiabetic Sprague-Dawley rats fed normal rodent chow to determine if the beta3 agonist could improve insulin sensitivity and/or responsiveness in the absence of weight loss or lowering of circulating FFAs. Subcutaneous miniosmotic pumps delivered either saline to control or 1 mg x kg(-1) x day(-1) of CL-316,243 for 10-12 days. Fed plasma glucose, insulin, and FFA levels were similar between the groups. Significant increases in food consumption, resting metabolic rates, and body core temperatures occurred, but only after 7 days of treatment. A 14% decrease in the respiratory quotient was also observed. Plasma glucose and insulin excursions in response to an oral glucose load (2 g/kg) on day 11 were unaltered. Cl-316,243 treatment resulted in a decrease in abdominal and epididymal white fat pad weights, while interscapular brown adipose tissue (IBAT) weight doubled. Basal and insulin-stimulated whole-body glucose disposal rates were increased, while hepatic glucose output was suppressed to a greater extent in the CL-316,243 animals after 10 days of uninterrupted treatment. Chronic treatment with CL-316,243 resulted in an increase in basal and insulin-stimulated [3H]2-deoxyglucose (2-DG) uptake by the retroperitoneal and epididymal white tissue and IBAT, but skeletal muscle 2-DG uptake under the same conditions was unaltered. These studies demonstrate that treatment with CL-316,243 improves basal and insulin-stimulated glucose disposal, and these effects occurred in the absence of a decrease in body weights and FFA concentrations. A particularly interesting observation was that the tissues responsible for this effect were white and brown adipose tissue, while skeletal muscle remained unaffected.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				I. Bogacka, T. W. Gettys, L. de Jonge, T. Nguyen, J. M. Smith, H. Xie, F. Greenway, and S. R. Smith The Effect of {beta}-Adrenergic and Peroxisome Proliferator-Activated Receptor-{gamma} Stimulation on Target Genes Related to Lipid Metabolism in Human Subcutaneous Adipose Tissue Diabetes Care, May 1, 2007; 30(5): 1179 - 1186. [Abstract] [Full Text] [PDF]

				H. Kim, P. A. Pennisi, O. Gavrilova, S. Pack, W. Jou, J. Setser-Portas, J. East-Palmer, Y. Tang, V. C. Manganiello, and D. LeRoith Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1227 - E1236. [Abstract] [Full Text] [PDF]

				J. G. Granneman, P. Li, Z. Zhu, and Y. Lu Metabolic and cellular plasticity in white adipose tissue I: effects of {beta}3-adrenergic receptor activation Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E608 - E616. [Abstract] [Full Text] [PDF]

				M. C. Moore, S. Cardin, D. S. Edgerton, B. Farmer, D. W. Neal, M. Lautz, and A. D. Cherrington Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E226 - E233. [Abstract] [Full Text] [PDF]

				J. G. Granneman, M. Burnazi, Z. Zhu, and L. A. Schwamb White adipose tissue contributes to UCP1-independent thermogenesis Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1230 - E1236. [Abstract] [Full Text] [PDF]

				B. Kalderon, N. Mayorek, L. Ben-Yaacov, and J. Bar-Tana Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E795 - E803. [Abstract] [Full Text] [PDF]

				R. S. Surwit, T. M. Dixon, A. E. Petro, K. W. Daniel, and S. Collins Diazoxide Restores {beta}3-Adrenergic Receptor Function in Diet-Induced Obesity and Diabetes Endocrinology, October 1, 2000; 141(10): 3630 - 3637. [Abstract] [Full Text] [PDF]

				E. GarcÍa-Rubi, R. D. Starling, A. Tchernof, D. E. Matthews, J. D. Walston, A. R. Shuldiner, K. Silver, E. T. Poehlman, and J. Calles-Escandón Trp64Arg Variant of the {beta}3-Adrenoceptor and Insulin Resistance in Obese Postmenopausal Women J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4002 - 4005. [Abstract] [Full Text]